These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8665154)

  • 1. Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts.
    Räisänen-Sokolowski A; Vuoristo P; Myllärniemi M; Yilmaz S; Kallio E; Häyry P
    Transpl Immunol; 1995 Dec; 3(4):342-51. PubMed ID: 8665154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat.
    Lemström KB; Räisänen-Sokolowski AK; Häyry PJ; Koskinen PK
    Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):553-64. PubMed ID: 8624778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial inhibition of allograft arteriosclerosis (chronic rejection) by 15-deoxyspergualin.
    Räisänen-Sokolowski A; Yilmaz S; Tufveson G; Häyry P
    Transplantation; 1994 Jun; 57(12):1772-7. PubMed ID: 8016883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts. Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis.
    Lemström KB; Aho PT; Bruggeman CA; Häyry PJ
    Arterioscler Thromb; 1994 Dec; 14(12):2043-52. PubMed ID: 7981194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts.
    Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeyoshi I; Morishita Y; Kobayashi E
    Transpl Immunol; 2004 Nov; 13(3):219-27. PubMed ID: 15381205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation.
    Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeuchi K; Takeyoshi I; Morishita Y; Kobayashi E
    Transplantation; 2004 Jun; 77(11):1661-7. PubMed ID: 15201664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
    Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
    Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mycophenolate mofetil on allograft arteriosclerosis (chronic rejection).
    Räisänen-Sokolowski A; Myllärniemi M; Häyry P
    Transplant Proc; 1994 Dec; 26(6):3225. PubMed ID: 7998125
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic rejection in the rat aortic allograft. V. Mechanism of the angiopeptin (BIM23014C) effect on the generation of allograft arteriosclerosis.
    Mennander A; Räisänen A; Paavonen T; Häyry P
    Transplantation; 1993 Jan; 55(1):124-8. PubMed ID: 8420036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat.
    Lemström KB; Bruning JH; Bruggeman CA; Koskinen PK; Aho PT; Yilmaz S; Lautenschlager IT; Häyry PJ
    Circulation; 1994 Oct; 90(4):1969-78. PubMed ID: 7923687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion.
    Hauser IA; Renders L; Radeke HH; Sterzel RB; Goppelt-Struebe M
    Nephrol Dial Transplant; 1999 Jan; 14(1):58-63. PubMed ID: 10052478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection.
    Klupp J; van Gelder T; Dambrin C; Regieli JJ; Boeke K; Billingham ME; Morris RE
    J Heart Lung Transplant; 2004 Mar; 23(3):334-51. PubMed ID: 15019644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment by mycophenolate mofetil of advanced graft vascular disease in non-human primate recipients of orthotopic aortic allografts.
    Klupp J; Dambrin C; Hibi K; Luna J; Suzuki T; Hausen B; Birsan T; Van Gelder T; Fitzgerald PJ; Berry G; Morris RE
    Am J Transplant; 2003 Jul; 3(7):817-29. PubMed ID: 12814473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat.
    Jolicoeur EM; Qi S; Xu D; Dumont L; Daloze P; Chen H
    Transplantation; 2003 Jan; 75(1):54-9. PubMed ID: 12544871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from cyclosporine to mycophenolate mofetil improves expression of A20 in the rat kidney allografts undergoing chronic rejection.
    Teng D; Lu Y; Gao R; Xin Y; Cao G; Li X; Wang L; Wang J; Wang L; Li Y
    Transplant Proc; 2006 Sep; 38(7):2164-7. PubMed ID: 16980032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of early chronic rejection in rat aortic allografts by mycophenolate mofetil (RS61443).
    Räisänen-Sokolowski A; Aho P; Myllärniemi M; Kallio E; Häyry P
    Transplant Proc; 1995 Feb; 27(1):435. PubMed ID: 7879051
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of the severity of acute rejection in the early phase after rat lung transplantation on the effectiveness of mycophenolate mofetil to treat chronic allograft rejection.
    von Suesskind-Schwendi M; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):142-8. PubMed ID: 22398468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts.
    Räisänen-Sokolowski AK; Pakkala IS; Samila SP; Binderup L; Häyry PJ; Pakkala ST
    Transplantation; 1997 Apr; 63(7):936-41. PubMed ID: 9112343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil treatment reduces atherosclerosis in the cholesterol-fed rabbit.
    Greenstein SM; Sun S; Calderon TM; Kim DY; Schreiber TC; Schechner RS; Tellis VA; Berman JW
    J Surg Res; 2000 Jun; 91(2):123-9. PubMed ID: 10839960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat.
    Vu MD; Qi S; Xu D; Wu J; Peng J; Daloze P; Sehgal S; Leduc B; Chen H
    Transplantation; 1998 Dec; 66(12):1575-80. PubMed ID: 9884242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.